Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
pUNO-mcs Human rhinovirus promotes STING trafficking to replication organelles to prom... 2022 Nat Commun Triantafilou M. et al. DOI: 10.1038/s41467-022-28745-3
Anti-Flagellin Salmonella Typhimurium O-antigen and VisP play an important role in swarming ... 2022 Braz J Microbiol. Manieri F.Z. & Moreira C.G. DOI: 10.1007/s42770-022-00701-9
HKSA BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell ... 2022 Acta Neuropathol Li R. et al. DOI: 10.1007/s00401-022-02411-w
ODN 2006 (ODN 7909) BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell ... 2022 Acta Neuropathol Li R. et al. DOI: 10.1007/s00401-022-02411-w
Human TLR9 Reporter HEK293 Cells Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ Null1 Cells Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ hTLR3 Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
Zeocin® Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ hTLR4 Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ hTLR2 Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
Blasticidin Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
QUANTI-Blue™ Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ hTLR5 Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
HEK-Blue™ Selection Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
Hygromycin B Gold Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
Normocin™ - Antimicrobial Reagent Modulation of outer membrane vesicle-based immune responses by cathelicidins. 2022 Vaccine Balhuizen M.D. et al. DOI: 10.1016/j.vaccine.2022.03.015
QUANTI-Luc™ A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... 2022 J Control Release Carson C.S. et al. DOI: 10.1016/j.jconrel.2022.03.020
THP1-Dual™ Cells A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... 2022 J Control Release Carson C.S. et al. DOI: 10.1016/j.jconrel.2022.03.020
QUANTI-Blue™ A nanovaccine for enhancing cellular immunity via cytosolic Co-delivery of an... 2022 J Control Release Carson C.S. et al. DOI: 10.1016/j.jconrel.2022.03.020
Poly(I:C) (HMW) VacciGrade™ The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual m... 2022 J Immunother Cancer Sum E. et al. DOI: 10.1136/jitc-2021-003264

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty